{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "a-synuclein",
        "Protein_Change": {
          "ref": "E",
          "alt": "K",
          "position": "46"
        },
        "variant_string_id": "asyn E46K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper describes how missense mutations in a-synuclein cause familial forms of Parkinson’s disease and dementia with Lewy bodies, and how a-synuclein is the major component of Lewy bodies and Lewy neurites that define these diseases.",
          "judgment": "Yes",
          "reasoning": "The paper discusses how missense mutations in a-synuclein are related to Parkinson’s disease, dementia with Lewy bodies, and the formation of Lewy bodies and Lewy neurites. This suggests that understanding the effects of these mutations on the properties of a-synuclein may shed light on their pathogenic nature."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper uses an assay to investigate the effects of mutations on the properties of a-synuclein, specifically focusing on changes in its interaction with other proteins and cells.",
          "judgment": "YES",
          "reasoning": "The general class of assay used (protein interaction assay) effectively models the molecular basis of Parkinson’s disease by investigating how mutations in a-synuclein affect its interactions with other proteins and cells, which are key factors in the disease's pathogenesis."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper includes both wild-type (normal/negative) and mutant (abnormal/positive) controls, and the experiments were performed multiple times.",
          "judgment": "YES",
          "reasoning": "The Materials and Methods section states that the experiments used both wild-type a-synuclein and mutated versions of the protein. Additionally, the Results section mentions replicates (performed in triplicate) for the experiments."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The study finds that the E46K mutation causes changes in a-synuclein's interaction with other proteins and cells, which could contribute to its pathogenic nature.",
          "judgment": "",
          "reasoning": "It is not explicitly stated whether statistical analyses were performed to estimate OddsPath for this variant. However, the study provides evidence that E46K mutation leads to changes in a-synuclein's interaction with other proteins and cells, which are key factors in the disease's pathogenesis."
        }
      ]
    }
  ]
}